RIL
VRDN icon

Rothschild Investment LLC’s Viridian Therapeutics VRDN Stock Holding History

Rothschild Investment LLC’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.66K Sell
136
-1
-0.7% -$30 ﹤0.01% 2408
2025
Q4 		$4.26K Buy
137
+7
+5% +$192 ﹤0.01% 1975
2025
Q3 		$2.81K Sell
130
-40
-24% -$721 ﹤0.01% 2011
2025
Q2 		$2.38K Buy
170
+55
+48% +$746 ﹤0.01% 1956
2025
Q1 		$1.55K Buy
115
+40
+53% +$681 ﹤0.01% 2063
2024
Q4 		$1.44K Buy
75
+5
+7% +$109 ﹤0.01% 2001
2024
Q3 		$1.59K Buy
70
+30
+75% +$490 ﹤0.01% 1849
2024
Q2 		$520 Buy
40
+35
+700% +$485 ﹤0.01% 1987
2024
Q1 		$88 Buy
+5
New +$97 ﹤0.01% 2237

Other funds holding VRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return